Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism

Matthew A. Chiarello; Akhilesh K. Sista

doi:10.1055/s-0038-1642041

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol 2018; 35(02): 122-128
DOI: 10.1055/s-0038-1642041

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism

Matthew A. Chiarello

¹Department of Radiology, New York University - Langone School of Medicine, New York, New York

,

Akhilesh K. Sista

²Division of Vascular and Interventional Radiology (VIR), Department of Radiology, New York University - Langone School of Medicine, New York, New York

› Author Affiliations

Abstract

Acute pulmonary embolism (PE) is a leading cause of morbidity and mortality in the United States. PE associated with right ventricular strain, termed submassive or intermediate-risk PE, is associated with an increased rate of clinical deterioration and short-term mortality. Trials have demonstrated systemic thrombolytics may improve patient outcomes, but they carry a risk of major hemorrhage. Catheter-directed thrombolysis (CDT) may offer similar efficacy to and a lower risk of catastrophic hemorrhage than systemic thrombolysis. Three prospective trials have evaluated CDT for submassive PE; ULTIMA, SEATTLE II, and PERFECT. These trials provide evidence that CDT may improve radiographic efficacy endpoints in submassive PE with acceptable rates of major hemorrhage. However, the lack of clinical endpoints, long-term follow-up, and adequate sample size limit their generalizability. Future trials should be adequately powered and controlled so that the short- and long-term effectiveness and safety of CDT can be definitively determined.

Keywords

Catheter-Directed Thrombolysis - submassive pulmonary embolism - ultrasound-assisted thrombolysis - interventional radiology

Full Text

References

References
1 Mozaffarian D, Benjamin EJ, Go AS. , et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 2015; 131 (04) e29-e322
2 Lim HY, Chua CC, Tacey M. , et al. Venous thromboembolism management in Northeast Melbourne: how does it compare to international guidelines and data?. Intern Med J 2017; 47 (09) 1034-1042
3 Jaff MR, McMurtry MS, Archer SL. , et al; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123 (16) 1788-1830
4 Konstantinides SV. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35 (45) 3145-3146
5 Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107 (23) (Suppl. 01) I22-I30
6 Grifoni S, Olivotto I, Cecchini P. , et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000; 101 (24) 2817-2822
7 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353 (9162): 1386-1389
8 Sista AK, Horowitz JM, Goldhaber SZ. Four key questions surrounding thrombolytic therapy for submassive pulmonary embolism. Vasc Med 2016; 21 (01) 47-52
9 Sista AK. Pulmonary embolism: the astute interventional radiology clinician. Semin Intervent Radiol 2017; 34 (01) 11-15
10 Meyer G, Vicaut E, Danays T. , et al; PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014; 370 (15) 1402-1411
11 Chatterjee S, Chakraborty A, Weinberg I. , et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA 2014; 311 (23) 2414-2421
12 Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. ; Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347 (15) 1143-1150
13 Wang TF, Squizzato A, Dentali F, Ageno W. The role of thrombolytic therapy in pulmonary embolism. Blood 2015; 125 (14) 2191-2199
14 Kucher N, Boekstegers P, Müller OJ. , et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014; 129 (04) 479-486
15 Piazza G, Hohlfelder B, Jaff MR. , et al; SEATTLE II Investigators. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study. JACC Cardiovasc Interv 2015; 8 (10) 1382-1392
16 Schmitz-Rode T, Kilbinger M, Günther RW. Simulated flow pattern in massive pulmonary embolism: significance for selective intrapulmonary thrombolysis. Cardiovasc Intervent Radiol 1998; 21 (03) 199-204
17 Lou BH, Wang LH, Chen Y. A meta-analysis of efficacy and safety of catheter-directed interventions in submassive pulmonary embolism. Eur Rev Med Pharmacol Sci 2017; 21 (01) 184-198
18 Dudzinski DM, Giri J, Rosenfield K. Interventional treatment of pulmonary embolism. Circ Cardiovasc Interv 2017; 10 (02) e004345
19 Tapson VF, Gurbel PA, Witty LA, Pieper KS, Stack RS. Pharmacomechanical thrombolysis of experimental pulmonary emboli. Rapid low-dose intraembolic therapy. Chest 1994; 106 (05) 1558-1562
20 Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M. ; “MOPETT” Investigators. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol 2013; 111 (02) 273-277
21 Wang C, Zhai Z, Yang Y. , et al; China Venous Thromboembolism (VTE) Study Group. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest 2010; 137 (02) 254-262
22 Avgerinos ED, Abou Ali AN, Liang NL. , et al. Predictors of failure and complications of catheter-directed interventions for pulmonary embolism. J Vasc Surg Venous Lymphat Disord 2017; 5 (03) 303-310
23 Kuo WT. Endovascular therapy for acute pulmonary embolism. J Vasc Interv Radiol 2012; 23 (02) 167-79.e4 , quiz 179
24 Biam D. Grossman's Cardiac Catheterization, Angiography, and Intervention, 7th ed. Philadelphia, PA: Lipponcott Williams & Wilkins; 2006: 235-240
25 Mills CS, Van Aman ME. Modified technique for percutaneous transfemoral pulmonary angiography. Cardiovasc Intervent Radiol 1986; 9 (01) 52-53
26 Zarghouni M, Charles HW, Maldonado TS, Deipolyi AR. Catheter-directed interventions for pulmonary embolism. Cardiovasc Diagn Ther 2016; 6 (06) 651-661
27 Sista AK, Kuo WT, Schiebler M, Madoff DC. Stratification, imaging, and management of acute massive and submassive pulmonary embolism. Radiology 2017; 284 (01) 5-24
28 Lee KA, Cha A, Kumar MH, Rezayat C, Sales CM. Catheter-directed, ultrasound-assisted thrombolysis is a safe and effective treatment for pulmonary embolism, even in high-risk patients. J Vasc Surg Venous Lymphat Disord 2017; 5 (02) 165-170
29 Engelberger RP, Kucher N. Ultrasound-assisted thrombolysis for acute pulmonary embolism: a systematic review. Eur Heart J 2014; 35 (12) 758-764
30 Lumsden AB, Suarez E. Interventional therapy for pulmonary embolism. Methodist DeBakey Cardiovasc J 2016; 12 (04) 219-224
31 Barjaktarevic I, Friedman O, Ishak C, Sista AK. Catheter-directed clot fragmentation using the Cleaner™ device in a patient presenting with massive pulmonary embolism. J Radiol Case Rep 2014; 8 (02) 30-36
32 Weinberg AS, Dohad S, Ramzy D, Madyoon H, Tapson VF. Clot extraction with the FlowTriever device in acute massive pulmonary embolism. J Intensive Care Med 2016; 31 (10) 676-679
33 Nakazawa K, Tajima H, Murata S, Kumita SI, Yamamoto T, Tanaka K. Catheter fragmentation of acute massive pulmonary thromboembolism: distal embolisation and pulmonary arterial pressure elevation. Br J Radiol 2008; 81 (971) 848-854
34 Schmitz-Rode T, Janssens U, Hanrath P, Günther RW. Fragmentation of massive pulmonary embolism by pigtail rotation catheter: possible complication. Eur Radiol 2001; 11 (10) 2047-2049
35 Francis CW, Blinc A, Lee S, Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 1995; 21 (03) 419-424
36 Motarjeme A. Ultrasound-enhanced thrombolysis. J Endovasc Ther 2007; 14 (02) 251-256
37 Lin PH, Annambhotla S, Bechara CF. , et al. Comparison of percutaneous ultrasound-accelerated thrombolysis versus catheter-directed thrombolysis in patients with acute massive pulmonary embolism. Vascular 2009; 17 (Suppl. 03) S137-S147
38 Engelberger RP, Spirk D, Willenberg T. , et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Circ Cardiovasc Interv 2015; 8 (01) e002027
39 Kuo WT, Banerjee A, Kim PS. , et al. Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): initial results from a prospective multicenter registry. Chest 2015; 148 (03) 667-673
40 Liang NL, Avgerinos ED, Marone LK, Singh MJ, Makaroun MS, Chaer RA. Comparative outcomes of ultrasound-assisted thrombolysis and standard catheter-directed thrombolysis in the treatment of acute pulmonary embolism. Vasc Endovascular Surg 2016; 50 (06) 405-410
41 Sista AK, Goldhaber SZ, Vedantham S. , et al. Research priorities in submassive pulmonary embolism: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol 2016; 27 (06) 787-794